Breaking News Instant updates and real-time market news.

AVLR

Avalara

$42.99

-0.51 (-1.17%)

15:36
09/20/18
09/20
15:36
09/20/18
15:36

Hedgeye names Avalara as new best idea short, Bloomberg says

  • 22

    Oct

AVLR Avalara
$42.99

-0.51 (-1.17%)

07/10/18
KEYB
07/10/18
INITIATION
KEYB
Sector Weight
Avalara initiated with a Sector Weight at KeyBanc
KeyBanc analyst Brent Bracelin started Avalara with a Sector Weight rating on valuation given investor optimism has been reflected in a share price that has risen 98% since the IPO. Nonetheless, the analyst has a bullish medium- to long-term view on Avalara based on its leadership in cloud software for sales tax compliance, differentiated tax content and software integrations, large $8B addressable market with less than 2% penetration, and long runway to sustain 20%-plus annual growth for the next decade.
07/16/18
JMPS
07/16/18
NO CHANGE
JMPS
Market Perform
Etsy comments hint at possible competitive moat for Avalara, says JMP Securities
After reviewing the South Dakota v. Wayfair Supreme Court opinion and some of the related Amicus Curiae briefs, JMP Securities analyst Patrick Walravens highlighted a comment from Etsy's (ETSY) brief that concluded that "given this complexity [of mapping thousands of tax codes to millions of unique products], it is doubtful that a software fix ever can be developed." Rather than doubting that a software solution can ever be developed, Walravens said he views the complexity referenced by Etsy as the market opportunity and potential competitive moat for Avalara, he tells investors. Still, Walravens believes Avalara is currently fairly valued and maintains his Market Perform rating on the shares.
08/15/18
GSCO
08/15/18
UPGRADE
Target $45
GSCO
Buy
Avalara upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Jesse Hulsing upgraded Avalara to Buy and kept his price target of $45, saying the company has "significantly underperformed" his coverage over the past month following a post-IPO overshoot and created an opportunity for investors. The analyst believes that Avalara will be the "category winner in the transaction tax compliance software market" and believes it is a compelling investment thanks to secular tailwind from ecommerce growth, lack of a competitive threat, and the catalyst of the recent South Dakota v. Wayfair Supreme Court ruling. Hulsing adds that a durable 20% or more growth for Avalara is likely, with upside for the stock from current levels after a 25% decline in price over the past two days.
08/16/18
08/16/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Lululemon (LULU) upgraded to Buy from Hold at Argus with analyst John Staszak citing the company's Q1 earnings beat and expectations of improved comps in Q2, along with its "substantial" growth opportunities to expand its brand overseas and particularly in China. 2. Kimberly-Clark (KMB) upgraded to Neutral from Underweight at JPMorgan analyst Andrea Teixeira saying while it remains to be seen if the company's recently announced price increases will "actually hold" given the intensely competitive U.S. market, she believes investors will give Kimberly-Clark shares the benefit of the doubt. 3. Embraer (ERJ) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Josh Milberg sayng the 29% selloff in the stock since its strategic partnership with Boeing (BA) was announced in early July has made the risk-reward attractive. 4. TechnipFMC (FTI) upgraded to Buy from Hold at Jefferies with analyst Mark Wilson saying same-year "book & turn" work and recent awards have lead him to raise his revenue forecasts through 2020. 5. Avalara (AVLR) upgraded to Buy from Neutral at Goldman Sachs with analyst Jesse Hulsing was saying the company has "significantly underperformed" his coverage over the past month following a post-IPO overshoot and created an opportunity for investors. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CTMX

CytomX Therapeutics

$15.76

0.44 (2.87%)

05:09
10/15/18
10/15
05:09
10/15/18
05:09
Initiation
CytomX Therapeutics initiated  »

CytomX Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPR

Tapestry

$43.81

1.13 (2.65%)

05:08
10/15/18
10/15
05:08
10/15/18
05:08
Downgrade
Tapestry rating change  »

Tapestry downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

EB

Eventbrite

$28.12

0.23 (0.82%)

05:04
10/15/18
10/15
05:04
10/15/18
05:04
Initiation
Eventbrite initiated  »

Eventbrite initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$32.66

0.31 (0.96%)

05:02
10/15/18
10/15
05:02
10/15/18
05:02
Initiation
Elanco initiated  »

Elanco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ZTS

Zoetis

$88.90

1.84 (2.11%)

04:59
10/15/18
10/15
04:59
10/15/18
04:59
Upgrade
Zoetis rating change  »

Zoetis upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

KSU

Kansas City Southern

$102.56

-0.41 (-0.40%)

04:57
10/15/18
10/15
04:57
10/15/18
04:57
Upgrade
Kansas City Southern rating change  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

04:55
10/15/18
10/15
04:55
10/15/18
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

04:55
10/15/18
10/15
04:55
10/15/18
04:55
General news
Breaking General news story  »

8-Week Bill Announcement…

REFR

Research Frontiers

$1.73

0.03 (1.76%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Research Frontiers management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

TEUM

Pareteum

$2.55

0.02 (0.79%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Pareteum management to meet with Lake Street »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

  • 07

    Nov

  • 15

    Nov

IHRT

iHeartMedia

$0.00

(0.00%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Cowen TMT analyst Vitanza to hold an analyst/industry conference call »

Technology, Media and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

OKE

Oneok

$64.99

-0.24 (-0.37%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Oneok management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

  • 31

    Oct

FDX

FedEx

$220.97

3.54 (1.63%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
FedEx management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

HRS

Harris

$154.88

0.61 (0.40%)

, LLL

L3 Technologies

$195.99

0.74 (0.38%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
L3 Technologies and Harris to hold a joint conference call »

The companies hold a…

HRS

Harris

$154.88

0.61 (0.40%)

LLL

L3 Technologies

$195.99

0.74 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

04:55
10/15/18
10/15
04:55
10/15/18
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

NXST

Nexstar

$74.10

0.2 (0.27%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Nexstar management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 08

    Nov

  • 13

    Nov

SLDB

Solid Biosciences

$34.19

-0.15 (-0.44%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Solid Biosciences has a conference call hosted by JPMorgan »

JPMorgan Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

GOL

Gol Linhas

$7.38

0.27 (3.80%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Gol Linhas management to meet with Buckingham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

ADBE

Adobe

$248.89

10.24 (4.29%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Adobe to host financial analyst meeting »

Financial Analyst Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

AET

Aetna

$200.91

1.83 (0.92%)

, CVS

CVS Health

$74.49

1.33 (1.82%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Cowen healthcare analysts to hold an analyst/industry conference call »

Healthcare Analysts,…

AET

Aetna

$200.91

1.83 (0.92%)

CVS

CVS Health

$74.49

1.33 (1.82%)

ESRX

Express Scripts

$94.29

0.55 (0.59%)

CI

Cigna

$207.05

1.04 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 01

    Nov

AET

Aetna

$200.91

1.83 (0.92%)

, CVS

CVS Health

$74.49

1.33 (1.82%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Cowen pharmaceuticals analyst to hold an analyst/industry conference call »

Healthcare Analysts,…

AET

Aetna

$200.91

1.83 (0.92%)

CVS

CVS Health

$74.49

1.33 (1.82%)

ESRX

Express Scripts

$94.29

0.55 (0.59%)

CI

Cigna

$207.05

1.04 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 01

    Nov

BPY

Brookfield Property

$19.57

0.06 (0.31%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Brookfield Property management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 01

    Nov

INTU

Intuit

$211.90

11.09 (5.52%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Intuit management to meet with RBC Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 21

    Oct

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Morgan Stanley China auto analysts to hold analyst/industry conference call »

U.S. Autos & Shared…

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Cowen pharmaceuticals analyst to hold an analyst/industry conference call »

Pharmaceuticals Analyst…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.